CoreRx, Inc. announces approval & pending commercial launch of Amphetamine Sulfate Tablets with long-standing client Bionpharma Inc. Read more
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer for Phase 2b clinical formulation and development Read more
CORERX, INC. ADDS PRODUCT DEVELOPMENT CENTER OF EXCELLENCE INCREASING PRODUCT DEVELOPMENT CAPACITY Read more
CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment Read more
CORERX, INC. ADDS INCREASING PRODUCT DEVELOPMENT CAPACITY Company to Continue Investments, Increase Workforce Read more
CoreRx and Aimmune Therapeutics Joint Expansion to Create Pharmaceutical Jobs and Increase the Base of Scientific Capabilities in the Tampa Bay Area Read more